Novartis AG
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come […]
Read More
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round […]
Read More
This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceutical therapy. It essentially delivers radiation directly into tumors by attaching a radioactive particle to a targeting molecule. RBC Capital Markets sees a $25 […]
Read More
A corner of the cancer therapy market is heating up—Here are the names investors need to know
There’s been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor. There are currently two products on the market from Novartis and a slew of clinical […]
Read More
Google’s Demis Hassabis is the gentleman tasked with turning bleeding-edge AI investigate into income
Demis Hassabis is a celebrated identify in synthetic intelligence investigate. He is a chess learn and a neuroscientist. On Wall Avenue, he’s fewer regarded. That may perhaps not be genuine for very long. Hassabis is emerging as the encounter of Google’s mammoth AI effort and on Tuesday will consider the stage at the annual developer’s […]
Read More
FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | Reuters The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged “junk” patents held by pharmaceutical companies for 20 brand-name drugs, including Novo Nordisk’s blockbuster drugs Ozempic, Saxenda and Victoza. The […]
Read More
Shares producing the most significant moves midday: Spotify, JetBlue, Danaher, Typical Motors and extra
Examine out the organizations building headlines in midday trading. Standard Motors — Shares rose much more than 4% immediately after the automaker exceeded analysts’ anticipations for its first-quarter benefits . Normal Motors posted adjusted earnings of $2.62 for each share on revenue of $43.01 billion. Analysts experienced anticipated earnings of $2.15 per share and income […]
Read More
European markets close 1.1% higher as UK’s FTSE 100 hits another record
UK stocks lag major bourses, sterling climbs after BOE chief economist comments Stock Chart IconStock chart icon FTSE 100 index. U.K. stocks remained in positive territory on Tuesday afternoon, with the blue-chip FTSE 100 index 0.25% higher at 3:50 p.m. London time, after Bank of England Chief Economist Huw Pill delivered a speech that was […]
Read More
Stocks making the biggest premarket moves: Normal Motors, GE Aerospace, Novartis, JetBlue and extra
Check out out the companies building the biggest moves in premarket buying and selling: Basic Motors — The automaker saw its stock increase 4% following it posted $2.62 for each share on revenues of $43.01 billion for the to start with quarter. Analysts anticipated $2.15 for each share on revenues of $41.92 billion, per LSEG. […]
Read More